EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological Factors Influencing Survival After Trimodality Treatment in Non-Metastatic Esophageal Cancer: A Retrospective Single-Center Study

Murat Yakin iD, Nilufer Bulut iD, Tanju Kapagan, Sevcan Genc iD, Ulviye Oflas, Sercan Yuksel iD, Gokmen Umut Erdem iD

Journal of Clinical Medicine · 15.06.2026 · 15 (12) · 4635

DOI: 10.3390/jcm15124635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.06.2026. Verfasst von Murat Yakin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In locally advanced squamous cell esophageal cancer, concurrent chemoradiotherapy (CRT) is the standard of care, as it especially improves local control and overall survival compared to radiotherapy alone. In contrast, treatment strategies for esophageal adenocarcinoma often parallel those used in gastric cancer, particularly regarding systemic therapy.

Objectives

This study aimed to evaluate the clinicopathological factors affecting event-free survival (EFS) and overall survival (OS) following trimodality treatment in patients with non-metastatic esophageal cancer.

Methods

A total of 155 patients diagnosed with esophageal cancer between March 2019 and November 2025 were retrospectively analyzed. Response to concurrent chemoradiotherapy was assessed via thoracic magnetic resonance imaging and endoscopic biopsy.

Results

Clinicopathological analysis showed that male sex, the presence of lymphovascular invasion, adenocarcinoma histology, poor pathological response and advanced-stage tumors were significantly associated with worse EFS (all p < 0.001). In multivariate analysis, stage IVa disease was identified as an independent predictor of both mortality and relapse, with an approximately five-fold increased risk of death (p = 0.028) and relapse (p = 0.019). Patients with squamous cell carcinoma had a longer median EFS compared to those with adenocarcinoma (18 vs. 8.4 months, respectively). The 3- and 5-year OS rates were 59.2% and 56% in patients with squamous cell carcinoma, compared with 40% and 26% in those with adenocarcinoma, respectively.

Conclusions

Survival outcomes were more favorable in patients with squamous cell histology and those diagnosed at an early stage. Active surveillance may be considered in selected patients with a complete clinical response to avoid the perioperative mortality associated with surgery.

Schlagwörter

Stichwörter der Autor:innen

chemoradiotherapyesophageal cancersurvival

Autor:innen und Institutionen

  • Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey.
  • Department of Medical Oncology, University of Health Sciences, 34668 Istanbul, Turkey.
  • Department of General Surgery, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey.

ORCID-Profile: Murat Yakin, Nilufer Bulut, Sevcan Genc, Sercan Yuksel, Gokmen Umut Erdem

Zitieren

APA

Yakin, M., Bulut, N., Kapagan, T., Genc, S., Oflas, U., Yuksel, S., & Erdem, G. U. (2026). Clinicopathological Factors Influencing Survival After Trimodality Treatment in Non-Metastatic Esophageal Cancer: A Retrospective Single-Center Study. Journal of Clinical Medicine, 15(12), 4635. https://doi.org/10.3390/jcm15124635

Vancouver

Yakin M, Bulut N, Kapagan T, Genc S, Oflas U, Yuksel S, et al. Clinicopathological Factors Influencing Survival After Trimodality Treatment in Non-Metastatic Esophageal Cancer: A Retrospective Single-Center Study. Journal of Clinical Medicine. 2026;15(12):4635. doi:10.3390/jcm15124635

BibTeX
@article{Yakin2026,
  author = {Yakin, Murat and Bulut, Nilufer and Kapagan, Tanju and Genc, Sevcan and Oflas, Ulviye and Yuksel, Sercan and Erdem, Gokmen Umut},
  title = {Clinicopathological Factors Influencing Survival After Trimodality Treatment in Non-Metastatic Esophageal Cancer: A Retrospective Single-Center Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4635},
  doi = {10.3390/jcm15124635}
}
Kostenlos starten →